Evidence mapPaperPMID 41599685Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

TAT-PBX1 Reverses Hyperglycemia Through β-Cell Regeneration and Functional Restoration in an STZ-Induced Diabetic Model.

Xiangyuan Meng, Zhenhu Zhao, Xin Zhang, Ruihan Guo, Shuran Yang, Shuhua Mao, Ziyu Zong, Jinyu Liu

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiangyuan MengSchool of Public Health, Jilin University, Changchun 130021, China.ORCID 0000-0002-6559-8504
Zhenhu ZhaoSchool of Public Health, Jilin University, Changchun 130021, China.
Xin ZhangSchool of Public Health, Jilin University, Changchun 130021, China.
Ruihan GuoSchool of Public Health, Jilin University, Changchun 130021, China.
Shuran YangSchool of Public Health, Jilin University, Changchun 130021, China.
Shuhua MaoSchool of Public Health, Jilin University, Changchun 130021, China.
Ziyu ZongSchool of Public Health, Jilin University, Changchun 130021, China.
Jinyu LiuSchool of Public Health, Jilin University, Changchun 130021, China.

Funding

Doctoral Research Innovation Program of the Jilin Provincial Department of Education JJKH20250213BSKey Technologies for the Pilot-Scale Preparation of Oral Insulin Products, Jilin University Technology Achievement Pilot Transformation Project 24GNYZ44Medjaden Academy & Research Foundation for Young Scientists MJR202510105National Natural Science Foundation of China 82273673Scientific Research Innovation Program for Doctoral Students, Jilin University 2024KC137
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetes mellitusglucokinasepancreatic β cellsPBX1STZ-induced diabetes

Identifiers

PMID41599685
PMCPMC12845013

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.